Inventor · disambiguated record
Liuhong Chen
Also filed as: CHEN LIUHONG
19 granted patents·22 pending applications·212 citations·filing 2018–2024
95Inventor score
Top patents by PatentIndex Score
41 records- 0197US11833211B2Methods of suppression and treatment of disease comprising administering bicycle peptide ligands specific for EphA2BICYCLETX LTD·Filed 2022·Granted Dec 5, 2023·15 cites·20 claims
- 0297US11542304B2Multimeric bicyclic peptide ligandsBICYCLETX LTD·Filed 2020·Granted Jan 3, 2023·14 cites·20 claims
- 0396US12049520B2Bicyclic peptide ligands specific for CD137BICYCLETX LTD·Filed 2022·Granted Jul 30, 2024·14 cites·24 claims
- 0496US11912792B2Bicyclic peptide ligands specific for nectin-4BICYCLETX LTD·Filed 2022·Granted Feb 27, 2024·14 cites·18 claims
- 0596US11484602B2Bicyclic peptide ligands specific for EphA2BICYCLETX LTD·Filed 2018·Granted Nov 1, 2022·16 cites·21 claims
- 0696US11453702B2Bicyclic peptide ligands specific for Nectin-4BICYCLETX LTD·Filed 2021·Granted Sep 27, 2022·16 cites·21 claims
- 0796US11180531B2Bicyclic peptide ligands specific for Nectin-4BICYCLETX LTD·Filed 2019·Granted Nov 23, 2021·18 cites·24 claims
- 0896US10875894B2Multimeric bicyclic peptide ligandsBICYCLETX LTD·Filed 2019·Granted Dec 29, 2020·26 cites·29 claims
- 0995US11696956B2Bicyclic peptide ligands specific for EphA2BICYCLETX LTD·Filed 2018·Granted Jul 11, 2023·18 cites·19 claims
- 1095US11261214B2Bicyclic peptide ligand specific for CD137BICYCLETX LTD·Filed 2018·Granted Mar 1, 2022·16 cites·25 claims
- 1194US11623012B2Bicyclic peptide ligands specific for EphA2BICYCLERD LTD·Filed 2018·Granted Apr 11, 2023·15 cites·9 claims
- 1293US11946041B2Modification of polypeptidesBICYCLERD LTD·Filed 2018·Granted Apr 2, 2024·14 cites·17 claims
- 1393US11613560B2Bicyclic peptide ligands specific for OX40BICYCLETX LTD·Filed 2020·Granted Mar 28, 2023·15 cites·26 claims
- 1489US12459974B2Bicyclic peptide ligands specific for Nectin-4BICYCLETX LTD·Filed 2024·Granted Nov 4, 2025·0 cites·11 claims
- 1588US2024400616A1Bicyclic peptide ligands specific for nectin-4BICYCLETX LTD·Filed 2024·Application pending·0 cites
- 1685US2024189436A1BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR EphA2BICYCLETX LTD·Filed 2023·Application pending·0 cites
- 1783US2024000957A1BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR EphA2BICYCLETX LTD·Filed 2023·Application pending·0 cites
- 1880US11866518B2Bicyclic peptide ligands specific for TSLPBICYCLETX LTD·Filed 2021·Granted Jan 9, 2024·1 cites·19 claims
- 1979US2025059236A1Bicyclic peptide ligands specific for cd137BICYCLETX LTD·Filed 2024·Application pending·0 cites
- 2075US12378288B2Multimeric bicyclic peptide ligandsBICYCLETX LTD·Filed 2022·Granted Aug 5, 2025·0 cites·29 claims
- 2173US2021269480A1Bicyclic peptide ligands specific for nectin-4BICYCLETX LTD·Filed 2019·Application pending·0 cites
- 2259US12377155B2Bicyclic peptide ligands specific for PSMABICYCLERD LTD·Filed 2019·Granted Aug 5, 2025·0 cites·14 claims
- 2358US2024091368A1Anti-infective bicyclic peptide ligandsBICYCLETX LTD·Filed 2022·Application pending·0 cites
- 2456US2024018508A1Phage cyclisation assayBICYCLERD LTD·Filed 2020·Application pending·0 cites
- 2555US2024108737A1Anti-infective bicyclic peptide ligandsBICYCLETX LTD·Filed 2022·Application pending·0 cites
- 2654US2024083945A1Anti-infective bicyclic peptide ligandsBICYCLETX LTD·Filed 2022·Application pending·0 cites
- 2752US2022281918A1Pbp binding bicyclic peptide ligandsBICYCLETX LTD·Filed 2020·Application pending·0 cites
- 2851US2023106511A1Pbp3 binding bicyclic peptide ligandsBICYCLETX LTD·Filed 2021·Application pending·0 cites
- 2951US2021207127A1Ligands and methods of selecting binding targets for suchBICYCLERD·Filed 2019·Application pending·0 cites
- 3051US2022008545A1BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR FAPaBICYCLERD LTD·Filed 2019·Application pending·0 cites
- 3150US12492224B2Bicyclic peptide ligands specific for PD-L1BICYCLETX LTD·Filed 2019·Granted Dec 9, 2025·0 cites·27 claims
- 3250US2022024982A1Bicyclic peptide ligands specific for mt1-mmpBICYCLETX LTD·Filed 2019·Application pending·0 cites
- 3349US2022133732A1Bicyclic peptide ligands specific for caixBICYCLERD LTD·Filed 2020·Application pending·0 cites
- 3449US2022088118A1Bicyclic peptide ligands specific for caixBICYCLETX LTD·Filed 2020·Application pending·0 cites
- 3548US2025325672A1Anti-infective bicyclic peptide ligandsBICYCLE TX LTD·Filed 2022·Application pending·0 cites
- 3648US2024083944A1Anti-infective bicyclic peptide ligandsBICYCLE TX LTD·Filed 2022·Application pending·0 cites
- 3747US2024108738A1Bicyclic peptide ligands specific for nk cellsBICYCLE TX LTD·Filed 2022·Application pending·0 cites
- 3846US2024197897A1Heterotandem bicyclic peptide complexesBICYCLE TX LTD·Filed 2022·Application pending·0 cites
- 3946US2022024983A1Bicyclic peptide ligands specific for il-17BICYCLERD LTD·Filed 2019·Application pending·0 cites
- 4043US2023183291A1Anti-infective bicyclic peptide ligandsBICYCLE TX LTD·Filed 2021·Application pending·0 cites
- 4142US11904020B2Bicyclic peptide ligands specific for TREM2BICYCLE TX LTD·Filed 2022·Granted Feb 20, 2024·0 cites·12 claims
Join the waitlist — get patent alerts
Get an alert when Liuhong Chen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →